525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028
Bang, Y.J, Doi, T, Braud, F. De, Piha-Paul, S, Hollebecque, A, Razak, A.R. Abdul, Lin, C.C, Ott, P.A, He, A.R, Yuan, S.S, Koshiji, M, Lam, B, Aggarwal, R
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
86P Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study
He, A.R., Valle, J.W., Lee, C-K., Ikeda, M., Potemski, P., Morizane, C., Cundom, J.E., Tougeron, D., Dayyani, F., Rokutanda, N., Xiong, J., Cohen, G., Oh, D-Y.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
181P Circulating tumor DNA (ctDNA) testing for recurrence and treatment response monitoring in hepatocellular carcinoma (HCC)
Abdelrahim, M., Mejia, A., Esmail, A., Ouf, M., Franses, J.W., Bhan, I., Sudha, K., Brdiges, C., Tin, T., Brewer, C., Aushev, V., Palsuledesai, C.C., Jurdi, A., Liu, M.C., Ghobrial, R.M., He, A.R.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
102P Potentially prognostic factors of overall survival in advanced biliary tract cancer in the randomised phase III TOPAZ-1 study
He, A.R., Bouattour, M., Gupta, V.G., Evesque, L., Zhen, D.B., Park, J.O., Sookprasert, A., Salvatierra, A., Vaccaro, G.M., Oh, S.C., Ostoich, S.A., Satoh, T., Żotkiewicz, M., Rokutanda, N., Kim, H., Oh, D-Y.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)
Abdelrahim, M., Esmail, A., He, A.R., Franses, J., Bhan, I., Victor, D.W., Kodali, S., Connor, A.A., Saharia, A., Brdiges, C., Tin, T., Brewer, C., Jurdi, A., Liu, M.C., Ghobrial, R.M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
418 POSTER A phase I trial of GMX1777: an inhibitor of nicotinamide phosphoribosyl transferase (NAMPRT)
Pishvaian, M.J, Hwang, J.H, Malik, S, He, A.R, Deeken, J.F, Kelso, C.B, Dorsch-Vogel, K, Berger, M.S, Marshall, J.L
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
965MO Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line (1L) treatment for unresectable hepatocellular carcinoma (uHCC): Expanded analyses from CheckMate 9DW
Decaens, T., Yau, T., Kudo, M., Sangro, B., Qin, S., Da Fonseca, L., Karachiwala, H., Park, J-W., Gane, E., Pinter, M., Tai, D.W.M., Santoro, A., Pizarro, G., Chiu, C-F., Schenker, M., He, A.R., Wang, Q., Ogata, T., Hreiki, J., Galle, P.R.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
55P Subsequent anticancer therapy (SAT) analysis from 3-year follow-up of the phase III TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in biliary tract cancer (BTC)
Vogel, A., Oh, D-Y., He, A.R., Qin, S., Chen, L-T., Okusaka, T., Kim, J.W., Suksombooncharoen, T., Lee, M.A., Kitano, M., Burris, H.A., Bouattour, M., Tanasanvimon, S., Zaucha, R.E., Avallone, A., Cundom, J.E., Kuzko, A., Wang, J., Xynos, I., Valle, J.W.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
279MO Three-year survival, safety and extended long-term survivor (eLTS) analysis from the phase III TOPAZ-1 study of durvalumab (D) plus chemotherapy in biliary tract cancer (BTC)
Oh, D-Y., He, A.R., Qin, S., Chen, L-T., Okusaka, T., Vogel, A., Kim, J.W., Suksombooncharoen, T., Lee, M.A., Kitano, M., Burris, H.A., Bouattour, M., Tanasanvimon, S., Zaucha, R.E., Avallone, A., Cundom, J.E., Kuzko, A., Wang, J., Xynos, I., Valle, J.W.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
Circulating tumor DNA monitoring for recurrence detection and treatment response assessment in HCC
Abdelrahim, M., Esmail, A., He, A.R., Victor, D., Kodali, S., Connor, A.A., Saharia, A., Bridges, C., Tin, A., Brewer, C., Aushev, V., Jurdi, A., Liu, M.C., Ghobrial, R.M.
Published in HPB (Oxford, England) (2024)
Published in HPB (Oxford, England) (2024)
Get full text
Journal Article
Corrigendum to “78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)”: [Annals of Oncology 33 (2022) S1462-S1463]
Oh, D., He, A.R., Qin, S., Chen, L., Okusaka, T., Vogel, A., Kim, J.W., Suksombooncharoen, T., Lee, M.A., Kitano, M., Burris, H.A., Bouattour, M., Tanasa, S., Zaucha, R.E., Avallone, A., Cundom, J.E., Rokutanda, N., Żotkiewicz, M., Cohen, G., Valle, J.W.
Published in Annals of oncology (01.07.2023)
Published in Annals of oncology (01.07.2023)
Get full text
Journal Article
409 POSTER A Phase I clinical trial of the oral PPAR gamma agonist, CS-7017 in patients with advanced malignancies
Pishvaian, M.J, Wagner, A, Deeken, J, He, A.R, Hwang, J, Malik, S, Cotarla, I, Demetri, G, Marshall, J.L, Wojtowicz-Praga, S
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
Melero, I., Yau, T., Kang, Y.-K., Kim, T.-Y., Santoro, A., Sangro, B., Kudo, M., Hou, M.-M., Matilla, A., Tovoli, F., Knox, J., He, A.R., El-Rayes, B., Acosta-Rivera, M., Lim, H.Y., Soleymani, S., Yao, J., Neely, J., Tschaika, M., Hsu, C., El-Khoueiry, A.B.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)
Oh, D-Y., He, A.R., Qin, S., Chen, L-T., Okusaka, T., Vogel, A., Kim, J.W., Lee, T., Lee, M.A., Kitano, M., Burris, H.A., Bouattour, M., Tanasanvimon, S., Zaucha, R.E., Avallone, A., Cundom, J.E., Rokutanda, N., Żotkiewicz, M., Cohen, G., Valle, J.W.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
83P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
Chan, S.L., Kudo, M., Sangro, B., Kelley, R.K., Furuse, J., Park, J-W., Sunpaweravong, P., Fasolo, A., Yau, T., Kawaoka, T., Cheng, A-L., Azevedo, S., Reig Monzon, M.E., Assenat, E., Yarchoan, M., He, A.R., Makowsky, M., Ran, D., Negro, A., Abou-Alfa, G.K.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
67O Outcomes in the Asian subgroup of the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
Chan, S.L., Kudo, M., Sangro, B., Kelley, R.K., Furuse, J., Park, J-W., Sunpaweravong, P., Fasolo, A., Yau, T., Kawaoka, T., Cheng, A-L., Azevedo, S., Reig Monzon, M.E., Assenat, E., Yarchoan, M., He, A.R., Makowsky, M., Gupta, C., Negro, A., Abou-Alfa, G.K.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
56P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)
Oh, D-Y., He, A.R., Qin, S., Chen, L-T., Okusaka, T., Vogel, A., Kim, J.W., Suksombooncharoen, T., Lee, M.A., Kitano, M., Burris, H.A., Bouattour, M., Tanasanvimon, S., Zaucha, R.E., Avallone, A., Cundom, J.E., Rokutanda, N., Watras, M., Cohen, G., Valle, J.W.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
714P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)
Chan, L.S., Kudo, M., Sangro, B., Kelley, R.K., Furuse, J., Park, J-W., Sunpaweravong, P., Fasolo, A., Yau, T., Kawaoka, T., Cheng, A-L., Azevedo, S., Reig Monzon, M.E., Assenat, E., Yarchoan, M., He, A.R., Makowsky, M., Ran, D., Negro, A., Abou-Alfa, G.K.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
A phase III, randomized, double-blind, placebo-controlled, international study of durvalumab in combination with gemcitabine plus cisplatin for patients with advanced biliary tract cancers: TOPAZ-1
Oh, D.-Y., Chen, L.-T., He, A.R., Okusaka, T., Qin, S., Chin, S., Rokutanda, N., Uchinda, H., Vogel, A., Valle, J.W., Kim, H.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
831TiP - A phase III, randomized, double-blind, placebo-controlled, international study of durvalumab in combination with gemcitabine plus cisplatin for patients with advanced biliary tract cancers: TOPAZ-1
Oh, D.-Y., Chen, L.-T., He, A.R., Okusaka, T., Qin, S., Chin, S., Rokutanda, N., Uchinda, H., Vogel, A., Valle, J.W., Kim, H.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article